Modification of human cancellous bone using Thai silk fibroin and gelatin for enhanced osteoconductive potential

Journal of Materials Science: Materials in Medicine

Volumn 24, Issue 3, 2013, Pages 735-744

  Vorrapakdee, Rungnapa ^a   Kanokpanont, Sorada ^a   Ratanavaraporn, Juthamas ^a   Waikakul, Saranatra ^b   Charoenlap, Chris ^a   Damrongsakkul, Siriporn ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW-DERIVED MESENCHYMAL STEM CELLS; BONE TISSUE ENGINEERING; CARBODIIMIDE HYDROCHLORIDES; COMPRESSIVE MODULI; OSTEOCONDUCTIVE; OSTEOGENIC DIFFERENTIATION; SOLUTION CONCENTRATION; THAI SILK FIBROINS;

BONE; CROSSLINKING; STEM CELLS;

SCAFFOLDS (BIOLOGY);

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; ALKALINE PHOSPHATASE; CALCIUM; CALCIUM PHOSPHATE; GELATIN; N HYDROXYSUCCINIMIDE; SILK FIBROIN;

ANIMAL CELL; ARTICLE; BIODEGRADATION; BONE CONDUCTION; BONE DEVELOPMENT; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CROSS LINKING; HUMAN; HUMAN TISSUE; MESENCHYMAL STEM CELL; NONHUMAN; POROSITY; PRIORITY JOURNAL; RAT; TISSUE ENGINEERING; TRABECULAR BONE;

BONE SUBSTITUTES; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; FIBROINS; GELATIN; HUMANS; MESENCHYMAL STROMAL CELLS; SILK; SPECTROMETRY, X-RAY EMISSION;

EID: 84876419630     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-012-4830-0     Document Type: Article

References (41)

1. Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920-6.
2. Newman JT, Smith WR, Ziran BH, Hasenboehler EA, Stahel PF, Morgan SJ. Efficacy of composite allograft and demineralized bone matrix graft in treating tibial plateau fractures with bone loss. Orthopedics. 2008;31:649.
3. Ozer K, Kiliç A, Sabel A, Ipaktchi K. The role of bone allografts in the treatment of angular malunions of the distal radius. J Hand Surg Am. 2011;36:1804-9.
4. Ehrler DM, Vaccaro AR. The use of allograft bone in lumbar spine surgery. Clin Orthop Relat Res. 2000;1:38-45.
5. Ziran BH, Hendi P, Smith WR, Westerheide K, Agudelo JF. Osseous healing with a composite of allograft and demineralized bone matrix: adverse effects of smoking. Am J Orthop. 2007;36:207-9.
6. Prasertsung I, Kanokpanont S, Bunaprasert T, Thanakit V, Damrongsakkul S. Development of acellular dermis from porcine skin using periodic pressurized technique. J Biomed Mater Res B Appl Biomater. 2008;85:210-9.
7. Jian YK, Tian XB, Li B, Qiu B, Zhou ZJ, Yang Z, Li QH. Properties of deproteinized bone for reparation of big segmental defect in long bone. Chin J Traumatol. 2008;11:152-6.
8. Nguyen H, Morgan DA, Forwood MR. Sterilization of allograft bone: is 25 kGy the gold standard for gamma irradiation? Cell Tissue Bank. 2007;8:81-91.
9. Meyer SR, Nagendran J, Desai LS, Rayat GR, Churchill TA, Anderson CC, Rajotte RV, Lakey JRT, Ross DB. Decellularization reduces the immune response to aortic valve allografts in the rat. J Thorac Cardiovasc Surg. 2005;130:469-76.
10. Ketonis C, Barr S, Adams CS, Hickok NJ, Parvizi J. Bacterial colonization of bone allografts: establishment and effects of antibiotics. Clin Orthop Relat Res. 2010;468:2113-21.
11. Kang H, Wang F. The modified bone-patellar tendon-bone allograft in single-bundle anterior cruciate ligament reconstruction. Acta Orthop Belg. 2011;77:390-3.
12. Cieslik M, Nocoń J, Rauch J, Cieslik T, Ślósarczyk A, Borczuch-Ła̧czka M, Owczarek A. Preparation of deproteinized human bone and its mixtures with bio-glass and tricalcium phosphate - innovative bioactive materials for skeletal tissue regeneration, tissue regeneration - from basic biology to clinical application. ISBN: 978-953-51-0387-5
13. Ketonis C, Barr S, Shapiro IM, Parvizi J, Adams CS, Hickok NJ. Antibacterial activity of bone allografts: comparison of a new vancomycin-tethered allograft with allograft loaded with adsorbed vancomycin. Bone. 2011;48:631-8.
14. Yamada H, Igarashi Y, Takasu Y, Saito H, Tsubouchi K. Identification of fibroin-derived peptides enhancing the proliferation of cultured human skin fibroblasts. Biomaterials. 2004;25:467-72.
15. Moy RL, Lee A, Zalka A. Commonly used suture materials in skin surgery. Am Fam Phys. 1991;44:2123-8.
16. Liu H, Fan H, Wang Y, Toh SL, Goh JCH. The interaction between a combined knitted silk scaffold and microporous silk sponge with human mesenchymal stem cells for ligament tissue engineering. Biomaterials. 2008;29:662-74.
17. Lovett ML, Cannizzaro CM, Vunjak-Novakovic G, Kaplan DL. Gel spinning of silk tubes for tissue engineering. Biomaterials. 2008;29:4650-7.
18. Bhardwaj N, Nguyen QT, Chen AC, Kaplan DL, Sah RL, Kundu SC. Potential of 3-D tissue constructs engineered from bovine chondrocytes/silk fibroin-chitosan for in vitro cartilage tissue engineering. Biomaterials. 2011;32:5773-81.
19. Wang Y, Blasioli DJ, Kim HJ, Kim HS, Kaplan DL. Cartilage tissue engineering with silk scaffolds and human articular chondrocytes. Biomaterials. 2006;27:4434-42.
20. Correia C, Bhumiratana S, Yan LP, Oliveira AL, Gimble JM, Rockwood D, Kaplan DL, Sousa RA, Reis RL, Vunjak-Novakovic G. Development of silk-based scaffolds for tissue engineering of bone from human adipose-derived stem cells. Acta Biomater. 2012;8:2483-92.
21. Vepari C, Kaplan DL. Silk as a biomaterial. Prog Polym Sci. 2007;32:991-1007.
22. Hersel U, Dahmen C, Kessler H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials. 2003;24:4385-415.
23. Jetbumpenkul P, Amornsudthiwat P, Kanokpanont S, Damrongsakkul S. Balanced electrostatic blending approach: an alternative to chemical crosslinking of Thai silk fibroin/gelatin scaffold. Int J Biol Macromol. 2012;50:7-13.
24. Chamchongkaset J, Kanokpanont S, Kaplan DL, Damrongsakkul S. Modification of Thai silk fibroin scaffolds by gelatin conjugation for tissue engineering. Adv Mater Res. 2008;55-57:685-8.
25. Kim UJ, Park J, Kim HJ, Wada M, Kaplan DL. Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials. 2005;26:2775-85.
26. Sofia S, McCarthy MB, Gronowicz G, Kaplan DL. Functionalized silk-based biomaterials for bone formation. J Biomed Mater Res. 2001;54:139-48.
27. Biman BM, Jasdeep KM, Kundu SC. Silk fibroin/gelatin multilayered films as a model system for controlled drug release. Eur J Pharm Sci. 2009;37:160-71.
28. Takahashi Y, Yamamoto M, Tabata Y. Osteogenic differentiation of mesenchymal stem cells in biodegradable sponges composed of gelatin and β-tricalcium phosphate. Biomaterials. 2005;26:3587-96.
29. Takahashi Y, Tabata Y. Homogeneous seeding of mesenchymal stem cells into nonwoven fabric for tissue engineering. Tissue Eng. 2003;9:931-8.
30. Paull B, Macka M, Haddad PR. Determination of calcium and magnesium in water samples by high-performance liquid chromatography on a graphitic stationary phase with a mobile phase containing O-cresolphthalein complexone. J Chromatogr A. 1997;789:329-37.
31. Okhawilai M, Rangkupan R, Kanokpanont S, Damrongsakkul S. Preparation of Thai silk fibroin/gelatin electrospun fiber mats for controlled release applications. Int J Biol Macromol. 2010;46:544-50.
32. Tomihata K, Ikada Y. Cross-linking of gelatin with carbodiimides. Tissue Eng. 1996;2:307-13.
33. Bloebaum RD, Bachus KN, Mitchell W, Hoffman G, Hofmann AA. Analysis of the bone surface area in resected Tibia. Implications in tibial component subsidence and fixation. Clin Orthop. 1994;309:2-10.
34. Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. Biomaterials. 2000;21:2529-43.
35. Yaszemski MJ, Payne RG, Hayes WC, Langer R, Mikos AG. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials. 1996;17:175-85.
36. Yasuhiko T, Ikada Y. Protein release from gelatin matrices. Adv Drug Deliver Rev. 1998;31:287-301.
37. Vachiraroj N, Ratanavaraporn J, Damrongsakkul S, Pichyangkura R, Banaprasert T, Kanokpanont S. A comparison of Thai silk fibroin-based and chitosan-based materials on in vitro biocompatibility for bone substitutes. Int J Biol Macromol. 2009;45:470-7.
38. Arpornmaeklong P, Suwatwirote N, Pripatnanont P, Oungbho K. Growth and differentiation of mouse osteoblasts on chitosan-collagen sponges. Int J Oral Maxillofac Surg. 2007;36:328-37.
39. He G, Dahl T, Veisand A, George A. Dentin matrix protein 1 initiates hydroxyapatite formation in vitro. Connect Tissue Res. 2003;44:240-5.
40. Li L, Buchet R, Wu Y. Dimethyl sulfoxide-induced hydroxyapatite formation: a biological model of matrix vesicle nucleation to screen inhibitors of mineralization. Anal Biochem. 2008;381:123-8.
41. Jung HJ, Park K, Son JS, Kim JJ, Han DK. Hydroxyapatite formation on acrylic acid-grafted porous PLLA scaffolds in simulated body fluid. In: 3rd Kuala Lumpur international conference on biomedical